Axial spondyloarthritis including ankylosing spondylitis.
作者信息
Braun Jürgen
机构信息
Rheumazentrum Ruhrgebiet, Herne, Germany.
出版信息
Rheumatology (Oxford). 2018 Aug 1;57(suppl_6):vi1-vi3. doi: 10.1093/rheumatology/key079.
Abstract
摘要
相似文献
1
Axial spondyloarthritis including ankylosing spondylitis.轴性脊柱关节炎，包括强直性脊柱炎。
Rheumatology (Oxford). 2018 Aug 1;57(suppl_6):vi1-vi3. doi: 10.1093/rheumatology/key079.
2
Pharmacologic treatment of psoriatic arthritis and axial spondyloarthritis with traditional biologic and non-biologic DMARDs.传统生物制剂和非生物 DMARDs 治疗银屑病关节炎和脊柱关节炎的药物治疗。
Best Pract Res Clin Rheumatol. 2014 Oct;28(5):793-806. doi: 10.1016/j.berh.2014.10.011. Epub 2014 Nov 22.
3
Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.简要报告：未经肿瘤坏死因子阻滞剂治疗的早期非放射性轴性脊柱关节炎和强直性脊柱炎患者的两年临床病程：来自德国脊柱关节炎起始队列的结果。
Arthritis Rheumatol. 2015 Sep;67(9):2369-75. doi: 10.1002/art.39225.
4
Axial spondyloarthritis: the heart of the matter.中轴型脊柱关节炎：问题的核心
Clin Rheumatol. 2015 Jun;34(6):995-8. doi: 10.1007/s10067-015-2959-1. Epub 2015 May 10.
5
Critical appraisal of the guidelines for the management of ankylosing spondylitis: disease-modifying antirheumatic drugs.强直性脊柱炎管理指南的批判性评价：改善病情抗风湿药物。
Am J Med Sci. 2012 May;343(5):357-9. doi: 10.1097/MAJ.0b013e3182513f9c.
6
Ankylosing Spondylitis and Axial Spondyloarthritis.强直性脊柱炎与中轴型脊柱关节炎
N Engl J Med. 2016 Sep 29;375(13):1303. doi: 10.1056/NEJMc1609622.
7
Ankylosing Spondylitis and Axial Spondyloarthritis.强直性脊柱炎与中轴型脊柱关节炎
N Engl J Med. 2016 Sep 29;375(13):1302. doi: 10.1056/NEJMc1609622.
8
Ankylosing Spondylitis and Axial Spondyloarthritis.强直性脊柱炎与中轴型脊柱关节炎
N Engl J Med. 2016 Sep 29;375(13):1302-3. doi: 10.1056/NEJMc1609622.
9
Placebo responses in ankylosing spondylitis patients worldwide: variations and possible explanations.全球强直性脊柱炎患者的安慰剂反应：差异及可能的解释。
Expert Rev Clin Immunol. 2020 May;16(5):447-450. doi: 10.1080/1744666X.2020.1748500. Epub 2020 Apr 3.
10
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis.吸烟的中轴型脊柱关节炎患者对肿瘤坏死因子 α 抑制剂治疗反应受损。
Ann Rheum Dis. 2016 Mar;75(3):532-9. doi: 10.1136/annrheumdis-2013-205133. Epub 2015 Feb 9.
引用本文的文献
1
An Overview of Adalimumab Therapy for Ankylosing Spondylitis.阿达木单抗治疗强直性脊柱炎概述。
Curr Rheumatol Rev. 2024;20(5):501-513. doi: 10.2174/0115733971289295240223095751.
2
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis.疼痛和炎症作为托法替布治疗强直性脊柱炎患者疲劳的疗效介导因素：一项中介分析
Rheumatol Ther. 2023 Aug;10(4):1073-1087. doi: 10.1007/s40744-023-00570-0. Epub 2023 Jun 23.
3
Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS Short Forms: a study in patients with axial spondyloarthritis.对症状、影响和选定的定制 PROMIS 短表进行定性概念发掘和认知性访谈：一项中轴型脊柱关节炎患者的研究。
J Patient Rep Outcomes. 2023 Apr 20;7(1):39. doi: 10.1186/s41687-023-00575-x.
4
Evaluation of preclinical efficacy of human umbilical cord mesenchymal stem cells in ankylosing spondylitis.评价人脐带间充质干细胞治疗强直性脊柱炎的临床前疗效。
Front Immunol. 2023 Mar 30;14:1153927. doi: 10.3389/fimmu.2023.1153927. eCollection 2023.
5
The effect of Aqua Stretching exercises and Pilates on pain, function and spine posture in patients with ankylosing spondylitis: a randomized controlled trial.水伸展运动和普拉提对强直性脊柱炎患者疼痛、功能及脊柱姿势的影响：一项随机对照试验
BMC Sports Sci Med Rehabil. 2022 Oct 21;14(1):183. doi: 10.1186/s13102-022-00577-0.
6
The Impact of a Theory-Based mHealth Intervention on Disease Knowledge, Self-efficacy, and Exercise Adherence Among Ankylosing Spondylitis Patients: Randomized Controlled Trial.基于理论的移动医疗干预对强直性脊柱炎患者疾病知识、自我效能和锻炼依从性的影响：随机对照试验。
J Med Internet Res. 2022 Oct 20;24(10):e38501. doi: 10.2196/38501.
7
Long-Term Adherence to Etanercept in Treatment Effectiveness of Patients with Spondyloarthritis: 7-Year Data from the Iraq National Registry.依那西普长期治疗强直性脊柱炎患者的疗效：来自伊拉克国家登记处的7年数据
Rheumatol Ther. 2022 Dec;9(6):1605-1616. doi: 10.1007/s40744-022-00497-y. Epub 2022 Sep 30.
8
The effects of golimumab on work productivity and quality of life among work-active axial spondyloarthritis and psoriatic arthritis patients treated in the routine care in Greece: the 'GO-UP' study.在希腊接受常规治疗的工作活跃型轴性脊柱关节炎和银屑病关节炎患者中，戈利木单抗对工作效率和生活质量的影响：“GO-UP”研究
Qual Life Res. 2022 May;31(5):1385-1399. doi: 10.1007/s11136-021-03044-4. Epub 2021 Nov 28.
9
Adalimumab and sulfasalazine in alleviating sacroiliac and aortic inflammation detected in PET/CT in patients with axial spondyloarthritis: PETSPA.阿达木单抗和柳氮磺胺吡啶缓解 PET/CT 检测到的中轴型脊柱关节炎患者的骶髂和主动脉炎症：PETSPA。
Immun Inflamm Dis. 2022 Feb;10(2):155-162. doi: 10.1002/iid3.552. Epub 2021 Nov 9.
10
Impact of tumor necrosis factor α inhibitors on MRI inflammation in axial spondyloarthritis assessed by Spondyloarthritis Research Consortium Canada score: A meta-analysis.加拿大脊柱关节炎研究联盟评分评估肿瘤坏死因子α抑制剂对轴性脊柱关节炎MRI炎症的影响：一项荟萃分析。
PLoS One. 2020 Dec 31;15(12):e0244788. doi: 10.1371/journal.pone.0244788. eCollection 2020.
本文引用的文献
1
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.肿瘤坏死因子阻滞剂通过降低疾病活动度抑制强直性脊柱炎的脊柱影像学进展：来自瑞士临床质量管理队列的结果
Ann Rheum Dis. 2018 Jan;77(1):63-69. doi: 10.1136/annrheumdis-2017-211544. Epub 2017 Sep 22.
2
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study.托法替布治疗强直性脊柱炎患者：一项为期16周的II期随机安慰剂对照剂量范围研究。
Ann Rheum Dis. 2017 Aug;76(8):1340-1347. doi: 10.1136/annrheumdis-2016-210322. Epub 2017 Jan 27.
3
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.2016 年更新的 ASAS-EULAR 中轴型脊柱关节炎管理推荐。
Ann Rheum Dis. 2017 Jun;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Epub 2017 Jan 13.
4
Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study.司库奇尤单抗治疗强直性脊柱炎的临床和放射学疗效：随机 III 期 MEASURE 1 研究的 2 年结果。
Ann Rheum Dis. 2017 Jun;76(6):1070-1077. doi: 10.1136/annrheumdis-2016-209730. Epub 2016 Dec 13.
5
Axial spondyloarthritis.中轴型脊柱关节炎。
Nat Rev Dis Primers. 2015 Jul 9;1:15013. doi: 10.1038/nrdp.2015.13.
6
Global Prevalence of Spondyloarthritis: A Systematic Review and Meta-Regression Analysis.脊柱关节炎的全球患病率：一项系统评价和Meta回归分析
Arthritis Care Res (Hoboken). 2016 Sep;68(9):1320-31. doi: 10.1002/acr.22831. Epub 2016 Jul 27.
7
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.司库奇尤单抗，一种白细胞介素-17A 抑制剂，治疗强直性脊柱炎。
N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066.
8
Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS).双氯芬酸治疗强直性脊柱炎连续与按需治疗 2 年对脊柱放射学进展的影响：一项随机多中心试验（ENRADAS）的结果。
Ann Rheum Dis. 2016 Aug;75(8):1438-43. doi: 10.1136/annrheumdis-2015-207897. Epub 2015 Aug 4.
9
Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS.强直性脊柱炎患者健康指数（ASAS HI）的制定：一项由ASAS指导、基于国际功能、残疾和健康分类（ICF）的全球倡议的最终结果。
Ann Rheum Dis. 2015 May;74(5):830-5. doi: 10.1136/annrheumdis-2013-203967. Epub 2014 Jan 7.
10
Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials.评估托珠单抗治疗强直性脊柱炎的短期症状疗效：随机、安慰剂对照试验的结果。
Ann Rheum Dis. 2014 Jan;73(1):95-100. doi: 10.1136/annrheumdis-2013-203559. Epub 2013 Jun 13.
Zotero 插件